Cellular senescence: a promising strategy for cancer therapy

키워드

참고문헌 (86)

1. Hayflick L, "The limited in vitro lifetime of human diploid cell strains", Exp Cell Res, 37, pp.614~636 (1965)
2. Campisi J, "Aging, cellular senescence, and cancer", Annu Rev Physiol, 75, pp.685~705 (2013)
3. Deng Y, "Role of telomeres and telomerase in genomic instability, senescence and cancer", Lab Invest, 87, pp.1071~1076 (2007)
4. Munoz-Espin D, "Programmed cell senescence during mammalian embryonic development", Cell, 155, pp.1104~1118 (2013)
5. Storer M, "Senescence is a developmental mechanism that contributes to embryonic growth and patterning", Cell, 155, pp.1119~1130 (2013)
6. Campisi J, "Cell biology : The beginning of the end", Nature, 505, pp.35~36 (2014)
7. Acosta JC, "Senescence : a new weapon for cancer therapy", Trends Cell Biol, 22, pp.211~219 (2012)
8. Itahana K, "Mechanisms of cellular senescence in human and mouse cells", Biogerontology, 5, pp.1~10 (2004)
9. Chang BD, "A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents", Cancer Res, 59, pp.3761~3767 (1999)
10. Chang BD, "Role of p53and p21waf1", cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs, 1999, pp.18, 4808~4818
11. 이민영, "Exploiting tumor cell senescence in anticancer therapy", BMB Reports, 47(2), pp.51~59 (2014), 생화학분자생물학회
12. Hernandez-Segura A, "Hallmarks of Cellular Senescence", Trends Cell Biol, 28, pp.436~453 (2018)
13. Myrianthopoulos V, "Senescence and senotherapeutics : a new field in cancer therapy", Pharmacol Ther, 193, pp.31~49 (2019)
14. Herranz N, "Mechanisms and functions of cellular senescence", J Clin Invest, 128, pp.1238~1246 (2018)
15. d'Adda di Fagagna F, "A DNA damage checkpoint response in telomereinitiated senescence", Nature, 426, pp.194~198 (2003)
16. Suram A, "Oncogeneinduced telomere dysfunction enforces cellular senescence in human cancer precursor lesions", EMBO J, 31, pp.2839~2851 (2012)
17. Shiloh Y, "The ATM-mediated DNA-damage response : taking shape", Trends Biochem Sci, 31, pp.402~410 (2006)
18. Celeste A, "Genomic instability in mice lacking histone H2AX", Science, 296, pp.922~927 (2002)
19. d'Adda di Fagagna F, "Living on a break : cellular senescence as a DNA-damage response", Nat Rev Cancer, 8, pp.512~522 (2008)
20. Lukas C, "Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage", Nat Cell Biol, 5, pp.255~260 (2003)
21. Turenne GA, "Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53", Oncogene, 20, pp.5100~5110 (2001)
22. Acosta JC, "A complex secretory program orchestrated by the inflammasome controls paracrine senescence", Nat Cell Biol, 15, pp.978~990 (2013)
23. Yoshimoto S, "Obesity induced gut microbial metabolite promotes liver cancer through senescence secretome", Nature, 499, pp.97~101 (2013)
24. Ohanna M, "Senescent cells develop a PARP-1 and nuclear factor-B-associated secretome(PNAS)", Genes Dev, 25, pp.1245~1261 (2011)
25. Wiley CD, "Mitochondrial dysfunction induces senescence with a distinct secretory phenotype", Cell Metab, 23, pp.303~314 (2016)
26. Kang C, "The DNA damage response induces inflammation and senescence by inhibiting autophagy of GATA4", Science, 349 (2015)
27. Kuilman T, "Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network", Cell, 133, pp.1019~1031 (2008)
28. Acosta JC, "Chemokine signaling via the CXCR2 receptor reinforces senescence", Cell, 133, pp.1006~1018 (2008)
29. Laberge RM, "MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation", Nat Cell Biol, 17, pp.1049~1061 (2015)
30. Herranz N, "mTOR regulates MAPKAPK2 translation to control the senescenceassociated secretory phenotype", Nat Cell Biol, 17, pp.1205~1217 (2015)
31. Hayakawa T, "SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation", PLoS One, 10, pp.e0116480~ (2015)
32. Chen H, "MacroH2A1 and ATM play opposing roles in paracrine senescence and the senescence-associated secretory phenotype", Mol Cell, 59, pp.719~731 (2015)
33. Capell BC, "MLL1 is essential for the senescence-associated secretory phenotype", Genes Dev, 30, pp.321~336 (2016)
34. Jung SH, "Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues", Cell Death Differ, 26, pp.245~259 (2018)
35. Ohno-Iwashita Y, "Plasma membrane microdomains in aging and disease", Geriatr Gerontol Int, 10, pp.S41~S52 (2010)
36. Kurz DJ, "Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells", J Cell Sci 113, 113, pp.3613~3622 (2000)
37. Sadaie M, "Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence", Genes Dev, 27, pp.1800~1808 (2013)
38. Salama R, "Cellular senescence and its effector programs", Genes Dev, 28, pp.99~114 (2014)
39. Nardella C, "Pro-senescence therapy for cancer treatment", Nat Rev Cancer, 11, pp.503~511 (2011)
40. Kim WY, "The regulation of INK4", ARF in cancer and aging, 2006, pp.127, 265~275
41. Bracken AP, "The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells", Genes Dev, 21, pp.525~530 (2007)
42. Alcorta DA, "Involvement of the cyclin-dependent kinase inhibitor p16(INK4a)in replicative senescence of normal human fibroblasts", Pro Natl Acad Sci U S A, 93, pp.13742~13747 (1996)
43. Wiley CD, "From ancient pathways to aging cells-connecting metabolism and cellular senescence", Cell Metab, 23, pp.1013~1021 (2016)
44. Jones RG, "AMP-activated protein kinase induces a p53-dependent metabolic checkpoint", Mol Cell, 18, pp.283~293 (2005)
45. Wang W, "Increased AMP : ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function", J Biol Chem, 278, pp.27016~27023 (2003)
46. Tran D, "Insulin-like growth factor-1 regulates the SIRT1-p53 pathway in cellular senescence", Aging Cell, 13, pp.669~678 (2014)
47. Angelini F, "Getting old through the blood : Circulating molecules in aging and senescence of cardiovascular regenerative cells", Front Cardiovasc Med, 4, pp.62~ (2017)
48. Michishita E, "Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins", Mol Biol Cell, 16, pp.4623~4635 (2005)
49. Ota H, "Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells", Oncogene, 25, pp.176~185 (2006)
50. Huang J, "SIRT1 overexpression antagonizes cellular senescence with activated ERK", S6k1signaling in human diploid fibroblasts, 2008, pp.3, e1710~
51. Langley E, "Human SIR2deacetylates p53 and antagonizes PML", p53-induced cellular senescence, 2002, pp.21, 2383~2396
52. Ong ALC, "Role of Sirtuin1-p53regulatory axis in aging, cancer and cellular reprogramming", Ageing Res Rev, 43, pp.64~80 (2018)
53. Blume-Jensen P, "Oncogenic kinase signalling", Nature, 411, pp.355~365 (2001)
54. Jung SH, "mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53", Oncogene (2018)
55. Schneider JL, "Autophagy and human disease : emerging themes", Curr Opin Genet Dev, 26, pp.16~23 (2014)
56. Chang J, "Spastic paraplegia proteins spastizin and spatacsin mediate autophagic lysosome reformation", J Clin Invest, 124, pp.5249~5262 (2014)
57. Gewirtz DA, "Autophagy and senescence : A partnership in search of definition", Autophagy, 9, pp.808~ (2013)
58. Kang C, "How autophagy both activates and inhibits cellular senescence", Autophagy, 12, pp.898~899 (2016)
59. Young AR, "Autophagy mediates the mitotic senescence transition", Genes Dev, 23, pp.798~803 (2009)
60. Mosieniak G, "Curcumin induces permanent growth arrest of human colon cancer cells : link between senescence and autophagy", Mech Ageing Dev, 133, pp.444~455 (2012)
61. Wang Y, "Autophagic activity dictates the cellular response to oncogenic RAS", Proc Natl Acad Sci U S A, 109, pp.13325~13330 (2012)
62. Kim BC, "Evaluation of premature senescence and senescence biomarkers in carcinoma cells and xenograft mice exposed to single or fractionated irradiation", Oncol Rep, 31, pp.2229~2235 (2014)
63. Ewald JA, "Therapy-induced senescence in cancer", J Natl Cancer Inst, 102, pp.1536~1546 (2010)
64. Ovadya Y, "Strategies targeting cellular senescence", J Clin Invest, 128, pp.1247~1254 (2018)
65. Yosef R, "p21maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling", EMBO J, 36, pp.2280~2295 (2017)
66. Vassilev LT, "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2", Science, 303, pp.844~848 (2004)
67. Alimonti A, "A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis", J Clin Invest, 120, pp.681~693 (2010)
68. Gembarska A, "MDM4 is a key therapeutic target in cutaneous melanoma", Nat Med, 18, pp.1239~1247 (2012)
69. Harajly M, "p53restoration in induction and maintenance of senescence : Differential effects in premalignant and malignant tumor cells", Mol Cell Biol, 36, pp.438~451 (2016)
70. Baar MP, "Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging", Cell, 169, pp.132~147 (2017)
71. Jung SH, "Heparan sulfation is essential for the prevention of cellular senescence", Cell Death Differ, 23, pp.417~429 (2016)
72. Lee JJ, "Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species", Oncogene, 29, pp.561~575 (2010)
73. Stambolic V, "Negative regulation of PKB", Akt-dependent cell survival by the tumor suppressor PTEN, 1998, pp.95, 29~39
74. Trotman LC, "Pten dose dictates cancer progression in the prostate", PLoS Biol, 1, pp.E5~ (2003)
75. Chen Z, "Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis", Nature, 436, pp.725~730 (2005)
76. Lee JJ, "PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation", Cell Death Differ, 18, pp.666~677 (2011)
77. Kalathur M, "A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours", Nat Commun, 6, pp.7227~ (2015)
78. Lapenna S, "Cell cycle kinases as therapeutic targets for cancer", Nat Rev Drug Discov, 8, pp.547~566 (2009)
79. Campaner S, "Cdk2suppresses cellular senescence induced by the c-myc oncogene", Nat Cell Biol, 12, pp.54~59 (2010)
80. Puyol M, "A synthetic lethal interaction between K-Ras oncogenes and Cdk4 unveils a therapeutic strategy for non-small cell lung carcinoma", Cancer Cell, 18, pp.63~73 (2010)
81. Lin HK, "Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence", Nature, 464, pp.374~379 (2010)
82. Kuilman T, "Senescence-messaging secretome : SMS-ing cellular stress", Nat Rev Cancer, 9, pp.81~94 (2009)
83. Coppe JP, "The senescence-associated secretory phenotype : the dark side of tumor suppression", Annu Rev Pathol, 5, pp.99~118 (2010)
84. Coppe JP, "Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence", J Biol Chem, 281, pp.29568~29574 (2006)
85. Coppe JP, "Senescenceassociated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor", PLoS Biol, 6, pp.2853~2868 (2008)
86. Han NK, "Secretome analysis of ionizing radiation-induced senescent cancer cells reveals that secreted RKIP plays a critical role in neighboring cell migration", Proteomics, 12, pp.2822~2832 (2012)

관련 논문AI추천